Osteopenia: Clinical Trials

16 trials for Osteopenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 16 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Completed 16
Phase 12Completed 2
Phase 31Completed 1

Follow Osteopenia: new trials by email Literature Review of Osteopenia trials Research Report on Osteopenia

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant
Denosumab - Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Osteopenia
Phase 2CompletedRoswell Park Cancer Institute302019-12-192024-03-13
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
Pamidronate, Calcium and vitamin D - Osteopenia, Osteoporosis
Phase 2CompletedMasonic Cancer Center, University of Minnesota632015-02-012024-02-20
Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density
BPS804 20mg/Kg, Placebo to 20mg/Kg BPS804 - Osteopenia, Osteoporosis
Phase 2CompletedUltragenyx Pharmaceutical Inc442011-07-012022-09-15
Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)
Zoledronic acid - HIV Infection, Bone Loss
Phase 2CompletedEmory University632011-01-012018-06-26
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
Oral calcitonin at dinnertime, Oral placebo at dinnertime, Oral calcitonin at bedtime - Osteopenia
Phase 2CompletedTarsa Therapeutics, Inc.1292011-01-012014-09-12
Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women
Standardized Extract of Olive Polyphenols, Placebo - Osteoporosis, Osteopenia
Phase 2CompletedBioActor642008-09-012017-07-13
Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
ONO-5334 - Osteoporosis, Osteopenia
Phase 2CompletedOno Pharma USA Inc2852007-10-012012-06-13
Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women
Hesperidin - Osteopenia, Osteoporosis
Phase 2CompletedSociété des Produits Nestlé (SPN)1442007-10-012015-10-06
Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
Recombinant Human Growth Hormone, Placebo for Recombinant Human Growth Hormone - Anorexia Nervosa, Osteopenia
Phase 2CompletedMassachusetts General Hospital212006-01-012020-09-02
Adding Phosphorus to Osteoporosis Drug Treatment
Calcium carbonate, Calcium Phosphate - Osteoporosis, Osteopenia
Phase 2CompletedCreighton University2412004-08-012016-07-06
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Pulsing electromagnetic field (PEMF) - Bone Disease, Metabolic, Osteopenia
Phase 1 / Phase 2CompletedNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)802003-11-012015-12-23
Bone Response to Soy Isoflavones in Women
Soy isoflavones, Extract tablets - Osteopenia, Osteoporosis
Phase 2CompletedIowa State University2242003-03-012013-02-07
Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women
Genistein - Menopause, Osteopenia
Phase 2 / Phase 3CompletedUniversity of Messina4002003-01-012008-04-22
Encouraging Calcium Absorption and Bone Formation During Early Puberty
Nondigestible oligosaccharide (NDO) - Osteoporosis, Osteopenia
Phase 1 / Phase 2CompletedBaylor College of Medicine1002001-05-012015-07-24
The Effect of Exercise in Postmenopausal Women with Low Bone Density
Exercise - Osteoporosis, Osteopenia
Phase 2CompletedUniversity of Melbourne382001-02-012024-12-09
Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
alendronate sodium, calcium carbonate, cholecalciferol - Gaucher's Disease, Osteopenia
Phase 2CompletedChildren's Hospital Medical Center, Cincinnati821998-10-012015-03-25

Narrower conditions

Bone Diseases, Metabolic (16)  ·  Osteoporosis (15)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Anorexia Nervosa (1)  ·  Bone Diseases (1)  ·  Bone Resorption (1)  ·  Feeding and Eating Disorders (1)  ·  Gaucher Disease (1)  ·  HIV Infections (1)  ·  Metabolism, Inborn Errors (1)  ·  Motor Activity (1)  ·  Musculoskeletal Diseases (1)  ·  Osteoporosis, Postmenopausal (1)  ·  Rare Diseases (1)  ·  Sphingolipidoses (1)

Broader conditions

Metabolic Diseases (16)  ·  Nutritional and Metabolic Diseases (16)  ·  Bone Diseases (15)  ·  Musculoskeletal Diseases (15)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Behavior (1)  ·  Blood-Borne Infections (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Central Nervous System Diseases (1)  ·  Communicable Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Calcium Carbonate (2)  ·  Cholecalciferol (2)  ·  Alendronate (1)  ·  Calcium (1)  ·  Denosumab (1)  ·  Ergocalciferols (1)  ·  Exercise (1)  ·  Genistein (1)  ·  Growth Hormone (1)  ·  Hesperidin (1)  ·  ONO-5334 (1)  ·  Pamidronate (1)  ·  Soybean Proteins (1)  ·  Vitamin D (1)  ·  Zoledronic Acid (1)

Sponsors

Baylor College of Medicine (1)  ·  BioActor (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Creighton University (1)  ·  Emory University (1)  ·  Iowa State University (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Massachusetts General Hospital (1)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)  ·  Ono Pharma USA Inc (1)  ·  Roswell Park Cancer Institute (1)  ·  Société des Produits Nestlé (SPN) (1)  ·  Tarsa Therapeutics, Inc. (1)  ·  Ultragenyx Pharmaceutical Inc (1)  ·  University of Melbourne (1)

Countries

United States (11)  ·  Australia (1)  ·  Israel (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Poland (1)

Top investigators

Anne Klibanski, MD (1)  ·  D. Lee Alekel, PhD (1)  ·  David S. Krause, MD (1)  ·  Francesco Squadrito, MD (1)  ·  Igho Ofotokun, MD, MSc (1)  ·  Joseph A. Spadaro, PhD (1)  ·  Kim L Bennell, PhD (1)  ·  Kyriakie Sarafoglou, MD (1)  ·  Mervyn N Weitzmann, PhD (1)  ·  Philip L McCarthy (1)  ·  Rafal Filip, MD PhD (1)  ·  Richard J. Wenstrup (1)  ·  Robert P. Heaney, MD (1)  ·  Steven A. Abrams, MD (1)

Results publications

PMID 15883634, PMID 16076940, PMID 16087995, PMID 17577003, PMID 17911175, PMID 19906801, PMID 20142790, PMID 20484446, PMID 20827548, PMID 23873670, PMID 25003624, PMID 25560820, PMID 27193748, PMID 31621838

NIH funding

R01AR043740 (1), R01AR046922 (1), R01AR048846 (1)